Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

19 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Stribild Articles

EU approval for Gilead's Stribild for HIV-1 infection

29 May 2013

EMA advisory backing for Biogen's Tecfidera, Sanofi's Aubagio and Gilead's Stribild; extends use of Bayer's Xarelto; negative for Kynamro

25 March 2013

Study on generic HIV drugs prompts AHF to demand Gilead cuts ARV prices

16 January 2013

Merck & Co and Gilead highlight new data at international HIV meeting

16 November 2012

Gilead's Stribild to reinforce HIV/AIDS revenues as key patents expire

6 November 2012

Gilead's Stribild, formerly "Quad," gets FDA nod

29 August 2012

Showing 1-6 of 6 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Additional indications in Japan for Roche's Avastin and Astellas' Prograf
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Additional indications in Japan for Roche's Avastin and Astellas' Prograf
  • US Supreme Court says patent settlement can "sometimes" be illegal

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS